The impact of cardiopulmonary hemodynamic factors in volumetry for pulmonary nodule management

BMC Medical Imaging - 2022
Erique Pinto1, Diana Penha1, Bruno Hochhegger2, Colin Monaghan3, Edson Marchiori4, Luís Taborda‐Barata1, Klaus Irion5
1Universidade da Beira Interior, Covilhã, Portugal
2Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil
3Imaging Department, Liverpool Heart and Chest Hospital NHS Foundation Trust: Liverpool, Liverpool, UK
4Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
5Imaging Department, University of Manchester, Manchester, UK

Tóm tắt

Abstract Background The acceptance of coronary CT angiogram (CCTA) scans in the management of stable angina has led to an exponential increase in studies performed and reported incidental findings, including pulmonary nodules (PN). Using low-dose CT scans, volumetry tools are used in growth assessment and risk stratification of PN between 5 and 8 mm in diameter. Volumetry of PN could also benefit from the increased temporal resolution of CCTA scans, potentially expediting clinical decisions when an incidental PN is first detected on a CCTA scan, and allow for better resource management and planning in a Radiology department. This study aims to investigate how cardiopulmonary hemodynamic factors impact the volumetry of PN using CCTA scans. These factors include the cardiac phase, vascular distance from the main pulmonary artery (MPA) to the nodule, difference of the MPA diameter between systole and diastole, nodule location, and cardiomegaly presence. Materials and methods Two readers reviewed all CCTA scans performed from 2016 to 2019 in a tertiary hospital and detected PN measuring between 5 and 8 mm in diameter. Each observer measured each nodule using two different software packages and in systole and diastole. A multiple linear regression model was applied, and inter-observer and inter-software agreement were assessed using intraclass correlation. Results A total of 195 nodules from 107 patients were included in this retrospective, cross-sectional and observational study. The regression model identified the vascular distance (p < 0.001), the difference of the MPA diameter between systole and diastole (p < 0.001), and the location within the lower or posterior thirds of the field of view (p < 0.001 each) as affecting the volume measurement. The cardiac phase was not significant in the model. There was a very high inter-observer agreement but no reasonable inter-software agreement between measurements. Conclusions PN volumetry using CCTA scans seems to be sensitive to cardiopulmonary hemodynamic changes independently of the cardiac phase. These might also be relevant to non-gated scans, such as during PN follow-up. The cardiopulmonary hemodynamic changes are a new limiting factor to PN volumetry. In addition, when a patient experiences an acute or deteriorating cardiopulmonary disease during PN follow-up, these hemodynamic changes could affect the PN growth estimation.

Từ khóa


Tài liệu tham khảo

Tzolos E, Newby DE. Coronary computed tomography angiography improving outcomes in patients with chest pain. Curr Cardiovasc Imaging Rep. 2019;12(5):1–10.

Moss AJ, Williams MC, Newby DE, Nicol ED. The Updated NICE Guidelines: cardiac CT as the first-line test for coronary artery disease. Curr Cardiovasc Imaging Rep. 2017;10(5):15.

Scholtz J-E, Lu MT, Hedgire S, Meyersohn NM, Oliveira GR, Prabhakar AM, et al. Incidental pulmonary nodules in emergent coronary CT angiography for suspected acute coronary syndrome: impact of revised 2017 Fleischner Society Guidelines. J Cardiovasc Comput Tomogr. 2018;12(1):28–33.

Ramanathan S, Ladumor SB, Francis W, Allam AA, Alkuwari M. Incidental non-cardiac findings in coronary computed tomography angiography: is it worth reporting? J Clin Imaging Sci. 2019;9(40):40.

Goehler A, McMahon PM, Lumish HS, Wu CC, Munshi V, Gilmore M, et al. Cost-effectiveness of follow-up of pulmonary nodules incidentally detected on cardiac computed tomographic angiography in patients with suspected coronary artery disease. Circulation. 2014;130(8):668–75.

Goo JM. MTE 27.02 pulmonary nodule guidelines: how do we decide between the IELCAP, ACCP, NCCN, Fleischner Society, BTS, and lung-RADS? J Thorac Oncol. 2017;12(11):S1654–5.

Callister MEJ, Baldwin DR, Akram AR, Barnard S, Cane P, Draffan J, et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE. Thorax. 2015;70(Suppl 2):ii1–54.

Graham RNJ, Baldwin DR, Callister MEJ, Gleeson FV. Return of the pulmonary nodule: the radiologist’s key role in implementing the 2015 BTS guidelines on the investigation and management of pulmonary nodules. Br J Radiol. 2016;89(1059):20150776.

MacMahon H, Naidich DP, Goo JM, Lee KS, Leung ANCC, Mayo JR, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology. 2017;284(1):228–43.

Henschke CI, Yip R, Shaham D, Zulueta JJ, Aguayo SM, Reeves AP, et al. The regimen of computed tomography screening for lung cancer: lessons learned over 25 years from the International Early Lung Cancer Action Program. J Thorac Imaging. 2021;36(1):6–23.

Chelala L, Hossain R, Kazerooni E, Christensen J, Dyer D, White CS. Lung-RADS version 1.1: challenges and a look ahead, from the AJR special series on radiology reporting and data systems. Am J Roentgenol. 2021;216:1411–22.

Wood DE, Kazerooni EA, Baum SL, Eapen GA, Ettinger DS, Hou L, et al. Lung cancer screening, version 3.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2018;16(4):412–41.

Walter JE, Heuvelmans MA, de Bock GH, Yousaf-Khan U, Groen HJM, van der Aalst CM, et al. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: the NELSON study. Lung Cancer. 2018;125:103–8.

Baldwin DR, Devaraj A. Lung cancer risk in new pulmonary nodules: implications for CT screening and nodule management. Lancet Oncol. 2016;17(7):849–50.

Bueno J, Landeras L, Chung JH. Updated Fleischner Society Guidelines for managing incidental pulmonary nodules: common questions and challenging scenarios. Radiographics. 2018;38(5):1337–50.

Watura C, Desai SR. Radiology report alerts - are emailed ‘Fail-Safe’ alerts acknowledged and acted upon? Int J Med Inform. 2020;133:104028.

Devaraj A, van Ginneken B, Nair A, Baldwin D. Use of volumetry for lung nodule management: theory and practice. Radiology. 2017;284(3):630–44.

Boll DT, Gilkeson RC, Fleiter TR, Blackham KA, Duerk JL, Lewin JS. Volumetric assessment of pulmonary nodules with ECG-gated MDCT. Am J Roentgenol. 2004;183(5):1217–23.

Helmberger M, Pienn M, Urschler M, Kullnig P, Stollberger R, Kovacs G, et al. Quantification of tortuosity and fractal dimension of the lung vessels in pulmonary hypertension patients. PLoS ONE. 2014;9(1):e87515.

Taylor BJ, Kjaergaard J, Snyder EM, Olson TP, Johnson BD. Pulmonary capillary recruitment in response to hypoxia in healthy humans: a possible role for hypoxic pulmonary venoconstriction? Respir Physiol Neurobiol. 2011;177(2):98–107.

Pienn M, Burgard C, Payer C, Avian A, Urschler M, Stollberger R, et al. Healthy lung vessel morphology derived from thoracic computed tomography. Front Physiol. 2018;9:346.

Soo E, Edey AJ, Mak SM, Moser J, Mohammadi S, Rodrigues T, et al. Impact of choice of volumetry software and nodule management guidelines on recall rates in lung cancer screening. Eur J Radiol. 2019;120:108646.

Talwar A, Willaime JMY, Pickup LC, Enescu M, Boukerroui D, Hickes W, et al. Pulmonary nodules: Assessing the imaging biomarkers of malignancy in a “coffee-break.” Eur J Radiol. 2018;101:82–6.

Thông tin
Thông tin xuất bản

BMC Medical Imaging

Thông tin tác giả